202 related articles for article (PubMed ID: 12445280)
1. Analysis of the B-cell repertoire against antigens expressed by human neoplasms.
Preuss KD; Zwick C; Bormann C; Neumann F; Pfreundschuh M
Immunol Rev; 2002 Oct; 188():43-50. PubMed ID: 12445280
[TBL] [Abstract][Full Text] [Related]
2. Exploitation of the B cell repertoire for the identification of human tumor antigens.
Pfreundschuh M
Cancer Chemother Pharmacol; 2000; 46 Suppl():S3-7. PubMed ID: 10950139
[TBL] [Abstract][Full Text] [Related]
3. Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens.
Türeci O; Sahin U; Zwick C; Neumann F; Pfreundschuh M
Hybridoma; 1999 Feb; 18(1):23-8. PubMed ID: 10211784
[TBL] [Abstract][Full Text] [Related]
4. Identification of tumour antigens by serological analysis of cDNA expression cloning.
Li G; Miles A; Line A; Rees RC
Cancer Immunol Immunother; 2004 Mar; 53(3):139-43. PubMed ID: 14722670
[TBL] [Abstract][Full Text] [Related]
5. Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method.
Nakatsura T; Senju S; Ito M; Nishimura Y; Itoh K
Eur J Immunol; 2002 Mar; 32(3):826-36. PubMed ID: 11870627
[TBL] [Abstract][Full Text] [Related]
6. Identification of tumor-associated autoantigens with SEREX.
Türeci O; Usener D; Schneider S; Sahin U
Methods Mol Med; 2005; 109():137-54. PubMed ID: 15585919
[TBL] [Abstract][Full Text] [Related]
7. Identification of human tumor antigens by serological analysis of recombinant cDNA expression libraries (SEREX).
Scanlan MJ
Curr Protoc Immunol; 2005 Mar; Chapter 20():Unit 20.7. PubMed ID: 18432945
[TBL] [Abstract][Full Text] [Related]
8. The reverse proteomics for identification of tumor antigens.
Lee SY; Jeoung D
J Microbiol Biotechnol; 2007 Jun; 17(6):879-90. PubMed ID: 18050904
[TBL] [Abstract][Full Text] [Related]
9. Identification of lymphoma-associated antigens using SEREX.
Liggins AP; Guinn BA; Banham AH
Methods Mol Med; 2005; 115():109-28. PubMed ID: 15998965
[TBL] [Abstract][Full Text] [Related]
10. Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients.
Mischo A; Wadle A; Wätzig K; Jäger D; Stockert E; Santiago D; Ritter G; Regitz E; Jäger E; Knuth A; Old L; Pfreundschuh M; Renner C
Cancer Immun; 2003 Jun; 3():5. PubMed ID: 12828452
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the antibody repertoire of lymphoma patients.
Huang S; Preuss KD; Xie X; Regitz E; Pfreundschuh M
Cancer Immunol Immunother; 2002 Dec; 51(11-12):655-62. PubMed ID: 12439611
[TBL] [Abstract][Full Text] [Related]
12. Mapping the high throughput SEREX technology screening for novel tumor antigens.
Zhou S; Yi T; Zhang B; Huang F; Huang H; Tang J; Zhao X
Comb Chem High Throughput Screen; 2012 Mar; 15(3):202-15. PubMed ID: 22221053
[TBL] [Abstract][Full Text] [Related]
13. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
[TBL] [Abstract][Full Text] [Related]
14. Serological analysis of human tumor antigens: molecular definition and implications.
Türeci O; Sahin U; Pfreundschuh M
Mol Med Today; 1997 Aug; 3(8):342-9. PubMed ID: 9269687
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of humoral response to tumor antigens using recombinant expression-based serological mini-arrays (SMARTA).
Lagarkova MA; Koroleva EP; Kuprash DV; Boitchenko VE; Kashkarova UA; Nedospasov SA; Shebzukhov YV
Immunol Lett; 2003 Jan; 85(1):71-4. PubMed ID: 12505200
[TBL] [Abstract][Full Text] [Related]
16. Potential target antigens for immunotherapy identified by serological expression cloning (SEREX).
Jäger D
Methods Mol Biol; 2007; 360():319-26. PubMed ID: 17172736
[TBL] [Abstract][Full Text] [Related]
17. Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display.
Fosså A; Alsøe L; Crameri R; Funderud S; Gaudernack G; Smeland EB
Cancer Immunol Immunother; 2004 May; 53(5):431-8. PubMed ID: 14747957
[TBL] [Abstract][Full Text] [Related]
18. [Human esophageal carcinoma antigens screened by serologic analysis of recombinant cDNA expression libraries (SEREX)].
Yu L; Hu H; Ran YL; Peng LP; Li JW; Yang ZH
Ai Zheng; 2007 Jan; 26(1):100-5. PubMed ID: 17222377
[TBL] [Abstract][Full Text] [Related]
19. CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
Yang XF; Wu CJ; Chen L; Alyea EP; Canning C; Kantoff P; Soiffer RJ; Dranoff G; Ritz J
Cancer Res; 2002 Oct; 62(19):5517-5522. PubMed ID: 12359762
[TBL] [Abstract][Full Text] [Related]
20. Antigens recognized by autologous antibody in patients with renal-cell carcinoma.
Scanlan MJ; Gordan JD; Williamson B; Stockert E; Bander NH; Jongeneel V; Gure AO; Jäger D; Jäger E; Knuth A; Chen YT; Old LJ
Int J Cancer; 1999 Nov; 83(4):456-64. PubMed ID: 10508479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]